GSK Receives FDA Approval for Chronic Disease Treatment
Pfizer Provides Data From German Trial of COVID-19 Vaccine
Eli Lilly Signs $800M Deal to Acquire Prevail Therapeutics
CA Launches Campaign for Safe, Fair COVID-19 Vaccine Distribution
Thermo Fisher Breaks Ground on Plasmid DNA Manufacturing Facility
AstraZeneca to Acquire Alexion in $39B Pharma Deal
HHS Doles Out Additional $227M for COVID-19 Vaccine Preparedness
Supreme Court Allows States to Regulate Pharmacy Benefit Managers
CMS Rule Allows Payers to Negotiate Prescription Drug Pricing
More Positive Data Released for Pfizer-BioNTech COVID-19 Vaccine
FDA Issues EUA for Abbott’s At-Home COVID-19 Antigen Test
FDA Issues Second COVID-19 Vaccine EUA to Moderna for mRNA Shot
US Buys Extra 100M Doses of Moderna’s COVID-19 Vaccine
FDA Authorizes First At-Home, OTC COVID-19 Diagnostic Test
Sanofi, GSK Halt Adjuvanted COVID-19 Vaccine Program
AstraZeneca Reports Positive Results in Cancer Drug Clinical Trial
Treameau Looks to Bring Back Vioxx for Non-Opioid Pain Relief
Canada Opts to Double Doses of Moderna’s COVID-19 Vaccine
Moderna Launches Study of COVID-19 Vaccine in Adolescents
Pharma Organizations Sue HHS Over Most Favored Nation Drug Rule
Roche to Include COVID-19 Antibody Test in Moderna’s Trials
Cerner Invests in Elligo to Boost Access to Clinical Trials
FDA Issues EUA For Pfizer-BioNTech COVID-19 Vaccine
FDA Says It Will Approve EUA for Pfizer’s COVID-19 Vaccine
Pfizer Reports Positive Data for Multiple Myeloma Antibody Drug
Ovid Therapeutics Rare Disease Drug Fails in Phase 3 Study
Eli Lilly, UnitedHealth Group Launch Study of COVID-19 Antibody
Bayer Launches Cell, Gene Therapy Platform for Pharma Innovation
HHS Ensures Access to COVID-19 Vaccines for Tribal Health Programs
FDA Authorizes First Influenza, COVID-19 Diagnostic Test
AbbVie, Frontier Medicines Partner to Develop Novel Drug Therapies
US Govt Purchases Additional 650,000 Doses of COVID-19 Antibody
Vaccination Implementation As Vital As Drug Efficacy, Study Finds
Roche Receives FDA Approval for COVID-19 Antibody Test
HHS, DoD to Increase Domestic Swab Production for COVID-19 Tests
GSK Initiates Phase 3 Study of RSV Maternal Vaccine Candidate
UK Approves COVID-19 Vaccine from Pfizer, BioNTech
HHS to Allocate Doses of Regeneron’s COVID-19 Antibody Therapy
Second Analysis Finds Moderna’s COVID-19 Vaccine 94.1% Effective
Rare Disease Drug from Alnylam Gets FDA Approval
Eli Lilly, Precision to Research Gene Therapies for Genetic Disorders
Considerations for Value-Based Drug Pricing During COVID-19
FDA Grants Emergency Use to Regeneron’s COVID-19 Antibody Cocktail
AstraZeneca’s COVID-19 Vaccine Meets Primary Endpoints
Siemens Healthineers Launches Improved COVID-19 Antibody Test
J&J Launches Second Global Trial of Lead COVID-19 Vaccine
Trump Issues New Rules to Lower Prescription Drug Pricing
Pfizer’s COVID-19 Vaccine Is Actually 95% Effective, New Data Shows
Placebo Elicits Same Side Effects As Cholesterol-Lowering Statins
Comparing COVID-19 Vaccine Candidates from Pfizer, Moderna
New PhRMA Guidelines Aim to Improve Clinical Trial Diversity
FDA Releases Guidance to Encourage Clinical Trial Diversity
COVID-19 Drug Discovery for Early Treatment Lacking, But Needed
Amazon Launches Its Own Pharmacy, Prescription Delivery Service
HHS Partners with Pharmacies to Boost Access to COVID-19 Vaccines
GSK, Medicago Start Phase 2 Trial of Adjuvanted COVID-19 Vaccine
Early Analysis Finds Moderna’s COVID-19 Vaccine Is 95% Effective
Overcoming the Challenges of Distributing COVID-19 Antibody Drugs
Automating Adherence Packaging Improves Medication Management
Boston Children’s Gets $65M for Drug Discovery Innovation
How Flu Vaccination Uptake Affects COVID-19 Vaccine Distribution
HHS Buys 300K Doses of Eli Lilly’s COVID-19 Antibody Treatment
Humanigen, DoD to Develop COVID-19 Antibody Treatment
Eli Lilly’s COVID-19 Antibody Treatment Approved for Emergency Use
FDA Authorizes Serology Test to Detect Neutralizing Antibodies
Merck Signs $2.75B Pharma Acquisition Deal with VelosBio
Pfizer’s COVID-19 Vaccine Is Over 90% Effective, Early Data Shows
Novartis to Develop Direct-Acting COVID-19 Antiviral Therapies
US Spending on Specialty Drugs Increases Year Over Year
New Thermo Fisher Deal Aims to Improve Biopharmaceutical Analysis
Sanofi Inks $359M Pharma Acquisition Deal to Boost Cell Therapy
HHS, DoD Announce $12.7M Contract to Increase COVID-19 Testing
FDA Publishes List of Essential Medicines to Address COVID-19
States Detail Specific Use of Abbott’s BinaxNOW COVID-19 Tests
Regeneron’s COVID-19 Antibody Cocktail Reduces Virus Levels
Epic’s Broad Pharmacy Development Increases But Gaps Remain
Eli Lilly Strikes Deal with Govt Over COVID-19 Antibody Drug
Definitive Healthcare Makes Another Key Life Sciences Acquisition
Thermo Fisher Scientific Supports Direct-to-Patient Clinical Trials
AstraZeneca Resumes Phase 3 US Trial for its COVID-19 Vaccine
Bayer Inks $4B Pharma Acquisition Deal to Boost Gene Therapy Base
Johnson & Johnson Resumes Phase 3 Trial of COVID-19 Vaccine
HHS Guidance Further Expands Access to COVID-19 Vaccines, Tests
Roche, Atea Pharmaceuticals to Develop Oral COVID-19 Antiviral
Overcoming the Top Challenges of COVID-19 Vaccine Distribution
FDA Approves Remdesivir as the First COVID-19 Treatment
Purdue Pharmaceuticals Pleads Guilty in $8.3B Opioid Settlement
Combating Antimicrobial Resistance Through Global Market Reform
CRISPR’s CAR-T Cell Therapy Shows Promise in Clinical Trial
Thermo Fisher Scientific to Expand At-Home COVID-19 Testing
Sanofi’s mRNA COVID-19 Vaccine Elicits High Antibody Levels
NIH Launches Trial to Test Immune Modulator Drugs for COVID-19
Half of Black Americans Would Not Get the COVID-19 Vaccine
Roche Developing High-Volume COVID-19 Antigen Testing Product
10 of the Largest Pharmaceutical Companies by Revenue
AstraZeneca’s COVID-19 Antibody Advances into Phase 3 Trials
Bristol Myers Squibb’s MS Drug Helps Ulcerative Colitis Patients
HHS, DoD to Scale-Up Manufacturing of COVID-19 Antibody Cocktail
Eli Lilly Announces Supply Deal for COVID-19 Antibody Therapies
Johnson & Johnson Pauses COVID-19 Vaccine Clinical Trial
Pfizer Doses First Patient in Study on Hemophilia A Gene Therapy
COVID-19 Antibody Cocktail Reduces Viral Levels, Regeneron Says
Insulin Prices 8x Higher in the US Compared to Similar Nations
GSK, Vir Biotechnology Expand Phase 3 Study of COVID-19 Antibody
FDA Issues Guidance for Emergency Use of COVID-19 Vaccines
64% of New Drug Indications Lacked Pediatric Prescribing Info
Johnson & Johnson Completes $6.5B Pharma Acquisition Deal
Major Pharma Companies Support Global Access to COVID-19 Vaccine
Hospitals Go Back to Purchasing Remdesivir from Distributor
HHS to Share Best Practices for Point-of-Care COVID-19 Testing
Abbott Enrolls First Patient in Spinal Cord Stimulation Study
CDC to Dole Out $200M for COVID-19 Vaccine Preparedness
Older Adults Likely to be Excluded from COVID-19 Vaccine Trials
ViiV Healthcare Launches Injectable HIV Treatment Study
Eli Lilly, Amgen Partner to Advance COVID-19 Antibody Therapies
Early Data Shows Promise for Johnson & Johnson’s COVID-19 Vaccine
Bristol Myers Squibb Reports Breakthrough with Immunotherapy Opdivo
Gilead to Pay $97M to Resolve Healthcare Fraud Allegations
FDA Finalizes Rule on Prescription Drug Importation from Canada
Bristol Myers Squibb Gets FDA Priority Review for T-Cell Therapy
Exploring the Most Favored Nation Approach for Drug Pricing
FDA Seeks to Clarify Evidence for Intended Use Determinations
J&J Initiates Global Phase 3 Clinical Trial for COVID-19 Vaccine
Global Effort Aims to Insure Against a Failed COVID-19 Vaccine
GSK, Sanofi to Supply 300M Doses of COVID-19 Vaccine to EU
Roche Launches Quantitative COVID-19 Antibody Test
Just Half of Americans Would Get a COVID-19 Vaccine If Ready Today
Immunotherapy Combo from Bristol Myers Squibb Improves Survival
HHS, DoD Release COVID-19 Vaccine Distribution Strategy
Bolstering the Pharmaceutical Supply Chain for a COVID-19 Vaccine
Prices of Brand Name Migraine Medications Continue to Increase
Brand Drug Product Hopping Costs US $4.7B Annually
Gauss, Cellex Launch First At-Home COVID-19 Antigen Test
Medicare Switches to Generic Cholesterol Drugs and Saves Billions
HHS Issues Guidance to Expand Access to COVID-19 Vaccines
J&J COVID-19 Vaccine Shows Promise in Preclinical Trial
Trump Pursues Most Favored Nation Strategy for Lower Drug Prices
Promoting Health Equity in COVID-19 Vaccine Clinical Trials
Systemic Corticosteroids Linked to Lower COVID-19 Mortality
Steps to Implement a Successful COVID-19 Vaccination Program
New Study Expounds Harms of Drug Rebates on Patients, Healthcare
Mylan, Biocon Biologics Launch Diabetes Biosimilar in the US
FDA Authorizes Faster COVID-19 Antigen Test from Abbott
Eli Lilly’s Diabetes Drug Jardiance Helps Heart Failure, Too
CEOs Pledge to Uphold Scientific Integrity for COVID-19 Vaccine
Breaking Down the Stages of Clinical Trials, Their Challenges
NIH Challenges Use of Convalescent Plasma to Treat COVID-19
AstraZeneca’s COVID-19 Vaccine Enters Phase 3 Clinical Trial
National Academy of Medicine Presents COVID-19 Vaccine Framework
Pharmaceutical M&A Activity Increased 17% in First Half of 2020
GSK, Vir Dose First Patient in Phase 2/3 COVID-19 Antibody Study
FDA Expands Remdesivir Use to All Hospitalized COVID-19 Patients
How EHR-Based Clinical Trials Can Accelerate Research Strategies
CMS Seeks Faster Medicare Coverage for Newly Approved Devices
Clinical Trial Design, Composition Has Undergone Major Changes
Early Positive Data for Pfizer’s mRNA COVID-19 Vaccine Candidate
Anticoagulation Therapy Improves Outcomes for COVID-19 Patients
BioMarin Receives FDA Complete Response Letter for Gene Therapy
Remdesivir May Not Greatly Help Moderately Ill COVID-19 Patients
Mylan Launches First Generic to Tecfidera Despite Patent Debate
Roche, Regeneron to Boost Supply of COVID-19 Antibody Combo
GSK Launches Phase 3 Trial for 5-in-1 Meningitis Vaccine
Johnson & Johnson Buys Momenta in $6.5B Pharma Acquisition Deal
FDA Authorizes Use of Convalescent Plasma as COVID-19 Treatment
HHS Authorizes Pharmacists to Administer Childhood Vaccines
Sanofi Inks $3.4B Pharma Acquisition Deal with Principia Biopharma
EU Launches Initiative to Accelerate COVID-19 Therapy Development
Bristol Myers Squibb Pays $475M to Acquire Immunotherapy Program
HHS, DoD Tap McKesson to Help with COVID-19 Vaccine Distribution
Drug Prices Increased over 25% for a Third of Products
FDA Grants Emergency Use Authorization to Yale for COVID-19 Test
AstraZeneca to Supply 400M Doses of COVID-19 Vaccine to EU
Pharma Sales Reps Must Understand Provider Needs During COVID-19
FDA Approves New Opioid For Intravenous Use in Hospitals
HHS, DoD to Manufacture 100M Doses of Moderna’s COVID-19 Vaccine
Third of Americans Would Pass on COVID-19 Vaccine If Ready Today
Pfizer to Manufacture Gilead’s Remdesivir for COVID-19 Treatment
Roche’s Tecentriq Fails in Phase 3 Breast Cancer Trial
AGs Lead Charge to Increase Access, Affordability of Remdesivir
Cost-Sharing for Privately Insured Increased for Brand Medicines
President Requires Government to Only Buy US-Made Essential Drugs
Coalition Calls on FDA to Ban Music in Certain Pharmaceutical Ads
Eli Lilly Launches Phase 3 Trial of COVID-19 Antibody Treatment
COVID R&D Alliance Starts Clinical Trial for Coronavirus Treatments
Johnson & Johnson’s Single Shot COVID-19 Vaccine Helps Monkeys
FDA Requires Drug Manufacturers to Update Opioid Labels
GSK, Sanofi to Supply 60M Doses of Its COVID-19 Vaccine to UK
Key Strategies for Advancing Gene and Cell Therapy Development
Thermo Fisher Scientific to Up Manufacturing of Cell Therapies
Disagreements Within FDA About Novel Drug Approvals Common
Pfzier, BioNTech Select mRNA COVID-19 Vaccine Candidate
Roche’s Arthritis Drug Fails in Phase III COVID-19 Treatment Study
Pull Funding May Combat COVID-19 Vaccine Development Challenges
Members of Congress Demand Transparency of Operation Warp Speed
Pharmaceutical Mergers, Acquisitions Down in First Half of 2020
Trump Aims to Lower Drug Prices Via PBM Reform, Drug Importation
Direct-Acting Antiviral Lowers Mortality Rate Among HCV Patients
Harvard Launches Spinout to Address mRNA, CRISPR Challenges
HHS Signs $1.95B Agreement to Produce Pfizer’s COVID-19 Vaccine
GSK, CureVac Partner to Manufacture mRNA Vaccines, Antibodies
Phase 3 Clinical Trial to Study Antibody for Alzheimer’s Disease
States Sue Mallinckrodt Over Underpaid Medicaid Drug Rebates
Oxford-AstraZeneca COVID-19 Vaccine Displays Immune Response
Emergency Use Authorization Issued for COVID-19 Pooled Testing
Eli Lilly Releases Positive Phase 3 Study Results for its Antibody
Dopamine Agonist Showed No Notable Benefit in Alzheimer’s Patients
Pharma Manufacturing Industry Ranks Second in R&D Intensity
Microsoft Alliance Targets Real-Time Visibility for Supply Chains
Oxford Scientists Develop Spinout to Launch COVID-19 Rapid Test
Pfizer, BioNTech Gain FDA Fast Track for COVID-19 Vaccine Candidates
Roche to Co-Develop Investigational Therapy for RET-Altered Cancers
Pfizer Commits $100M to Help Fight Rise of Antimicrobial Resistance
Gilead Releases Additional Data on COVID-19 Antiviral, Remdesivir
HHS, DOD, Novavax Partner to Scale-Up COVID-19 Vaccine Doses
GSK, Medicago, to Develop Novel Adjuvanted COVID-19 Vaccine
Invoice-Based Drug Reimbursement Did Not Cut Medicaid Spending
Is Germany’s Drug Pricing Strategy An Option for the US?
Novartis to Pay $642M to Resolve Healthcare Fraud Allegations
Kevzara Fails in Phase 3 COVID-19 Clinical Trial
FDA Grants EUA for Becton Dickinson’s Rapid COVID-19 Antigen Test
FDA Releases Guidance on COVID-19 Vaccine Development
Judge Thwarts Biosimilar Competition For Amgen’s Enbrel
Pfizer Reports Positive Results for Potential COVID-19 Vaccine
Remdesivir’s $2,340 Price Tag Well Below Value, Gilead CEO Says
Pharmaceutical Companies Hike Drug Prices During COVID-19 Pandemic
DOJ Charges Another Generic Drug Company with Price Setting
Gilead Will Acquire Equity in Pionyr Immunotherapeutics for $275M
Abbott to Create Diabetes Management Solutions with Tandem
ICER Raises Pricing Recommendation for COVID-19 Drug Remdesivir
FDA Backs New Effort to Repurpose Drugs As COVID-19 Treatments
Children’s Robitussin, Dimetapp Recalled Due to Overdose Risk
Walmart Acquires Pharmacy Management Capabilities from CareZone
FDA Oks Botox As a Biologic for Pediatric Urology Patients
WHO Halts Hydroxychloroquine Study After Seeing No COVID-19 Benefit
Insulin, GLP-1 RA Combo Improves Blood Sugar Control for Diabetics
AbbVie, Genmab Team Up for Antibody Therapeutics for Cancer
Eli Lilly Starts Phase 3 Study of RA Drug as COVID-19 Treatment
Phase 3 Study Finds Roche’s Acute Myeloid Leukemia Drug Effective
Trulicity Beats Others in Patient Adherence, Real World Data Shows
FDA Rescinds Emergency Use Authorization for COVID-19 Antibody Test
AstraZeneca’s Calquence Shows Improvement in Two Clinical Trials
Steroid Dexamethasone Reduces COVID-19 Deaths, Initial Data Shows
Coalition of AGs Accuse 26 Generic Drug Companies of Price Fixing
Merck Earns Approval for Drug Targeting Hospital-Acquired Infection
AstraZeneca, Accent Therapeutics to Create Novel Cancer Therapies
FDA Reverses Emergency Use Authorization for Hydroxychloroquine
Delayed Generic Drug Entry Cost Medicaid $761M, Study Finds
Phase 3 Trial Finds AbbVie’s Rheumatoid Arthritis Drug Effective
Top COVID-19 Vaccines, Treatments Moving Forward in Clinical Trials
FDA Issues Guidance on Patient Access Requests During COVID-19
Phase 1 Study Starts for Lilly’s Second COVID-19 Antibody Treatment
D-cycloserine Augments Exposure Therapy for SAD, Trial Finds
Clinical Trial Finds Hydroxychloroquine Does Not Prevent COVID-19
Combination Antibody Therapy Reduces Relapsed Multiple Myeloma
Eli Lilly Launches Global Study of COVID-19 Antibody Treatments
Cancer Clinical Trial Enrollment Fell During COVID-19 Pandemic
FDA Approves Eli Lilly’s Tau Pathology Drug For Alzheimer’s
Moderna Doses First Patients in Phase 2 Study of COVID-19 Vaccine
$628M HHS Task Order to Advance Manufacturing of COVID-19 Vaccines
Gilead Reports Remdesivir Helped Moderately Ill COVID-19 Patients
Bristol Myers Squibb Announces Commercial Launch of MS Drug
Antidepressant Ineffective Against Apathy in Alzheimer’s Patients
GSK to Manufacture 1B Doses of COVID-19 Vaccine Adjuvant System
Bristol Myers Squibb Drug Ineffective for Recurrent Glioblastoma
Robust Biosimilars Market Promotes High Savings, Affordability
Obtaining Contraceptives from Pharmacists Boosts Continuous Adherence
Merck and IAVI Partner to Develop Potential COVID-19 Vaccine
COVID-19 May Negatively Impact the Biopharmaceutical Industry
Teva Walks Away from Negotiations Over Healthcare Fraud Charges
HHS to Expand US-Based Pharmaceutical Manufacturing for COVID-19
AstraZeneca Inks Deals to Supply 400M Doses of a COVID-19 Vaccine
Study Identifies Potential Therapeutic COVID-19 Antibody
FDA OKs Roche’s First-Line Treatment for Some Lung Cancers
GSK Touts HIV Prevention Breakthrough with Long-Acting Injection
White House Unveils Plans to Advance COVID-19 Vaccine Development
6 Pharmacy Owners, Marketers Charged in $14M Healthcare Fraud Case
FDA Rejects Bristol Myers Cell Squibb’s CAR T-Cell Therapy
Positive Trial Data for Moderna’s COVID-19 Vaccine Candidate
FDA Approves Lilly’s Advanced Lung, Thyroid Cancer Drug
FDA Grants Emergency Use Authorization for COVID-19 Serology Test
Cybersecurity Best Practices for the Pharma Sector Amid COVID-19
Generic Drug Company Pays $24.1M to Resolve Antitrust Violations
FDA Issues Emergency Use Authorization for COVID-19 Antigen Test
HHS Reveals Plan for Shipping Remdesivir to Hospitals for COVID-19
Apple Awards $10M to Give Hospitals COVID-19 Testing Kits
Researchers Link HSV-1 to Alzheimer’s, Creating Hope for a Cure
Phase 3 Trial Finds Positive Results for Microbiome Treatment
Continuous Buprenorphine Treatment Lowers Prescription Opioid Use
Price for COVID-19 Treatment May Range from $10 to $4K, ICER Says
FDA Authorizes Emergency Use of Remdesivir to Treat COVID-19
Lilly, Junshi Biosciences to Develop COVID-19 Antibody Therapies
Pfizer, BioNTech Dose First Participants in COVID-19 Vaccine Trial
GSK Gains FDA Approval for its PARP Inhibitor Cancer Treatment
Pfizer, Valneva Commercialize Lyme Disease Vaccine Candidate
Janssen Advances Alveo’s At-Home COVID-19 Testing Platform
Demand for Cardiovascular Drugs Increases as COVID-19 Cases Soar
Merck Reports Decrease in Pharmaceutical Revenue Due to COVID-19
Lawmakers Uncover Significant Gaps in COVID-19 Antibody Testing
66% of Adults Report Prescription Drug Price Increases Since 2017
COVID-19 Clinical Trial Questions High Doses of Chloroquine
Gilead Hints at Remdesivir’s Potential as a COVID-19 Treatment
Gilead, Kite Ink Deal with oNKo-innate for Cancer Immunotherapies
Sanofi Scores FDA Approval for Quadrivalent Meningitis Vaccine
Johnson & Johnson Expands Manufacturing of Lead COVID-19 Vaccine
FDA Warns of Heart Rhythm Issues with Promising COVID-19 Drugs
Bristol Myers Squibb, Exelixis Drug Combo Helping Kidney Cancer
BARDA Gives $483M to Moderna for COVID-19 Vaccine Development
Early Data Shows No Benefit of Hydroxychloroquine for COVID-19
Biogen Partners with MA Health Orgs to Launch COVID-19 Biobank
BARDA Director Rick Bright Leaves Agency Amid COVID-19 Pandemic
Pfizer, BioNTech Team Up to Advance COVID-19 Vaccine Development
Novartis Donates 130M Doses of Hydroxychloroquine to Combat COVID-19
Roche Launches Serology Test to Uncover COVID-19 Antibodies
NIH Ties Up with Top Pharma Companies for COVID-19 Drug Discovery
PBM Reimbursement Significantly Varies for Generic Drugs
CRISPR Technology Detects COVID-19 From Respiratory RNA Extracts
FDA Approves Selumetinib for Rare Pediatric Neurofibromatosis
Eli Lilly Arthritis Drug Being Tested in COVID-19 Clinical Trial
Premier Presses FDA, FTC for Biosimilar Marketplace Competition
Sanofi, GSK Partner to Develop Adjuvanted COVID-19 Vaccine
Manufacturing Costs of Potential COVID-19 Drugs as Low as $1
Early Data Indicates Remdesivir is a Promising COVID-19 Drug
Recent FDA Approvals to Target Chronic Disease Management
COVID-19 Spurs Eli Lilly to Drop Insulin Costs to $35 a Month
NIH Launches Clinical Trial of Hydroxychloroquine for COVID-19
Sage Reduces its Workforce by Over 50% Due to COVID-19 Pandemic
Pfizer Commits $40M in Grants to Combat COVID-19 Pandemic
Alynlam, Dicerna Partner on RNAi Therapeutics for Liver Disease
Henry Ford to Study Use of Hydroxychloroquine to Prevent COVID-19
GSK, Vir Use CRISPR, Artificial Intelligence to Find COVID-19 Cure
ASHP Demands More Manufacturing of Ventilator Drugs for COVID-19
FDA Orders Removal of Prescription, OTC Ranitidine Drugs
4 of the Most Promising COVID-19 Vaccines In Development
Key Prescription Drugs Being Used to Treat COVID-19 Patients
New Study Finds Significant Cost Savings from Biosimilars Use
Mylan, Pfizer Delay Major Pharmaceutical Merger Due to COVID-19
Gilead Expands Access to Potential COVID-19 Treatment, Remdesivir
FDA Issues Guidance on Conducting Clinical Trials During COVID-19
Johnson & Johnson Announces a Lead COVID-19 Vaccine Candidate
FDA Accelerates Review of COVID-19 Diagnostic Tests
Bristol Myers Scores FDA Approval for Celgene’s MS Drug Ozanimod
FDA Approves Prescription Digital Therapeutic for Chronic Insomnia
How the Pharmaceutical Industry Is Approaching a COVID-19 Vaccine
Gilead Requests FDA to Rescind Orphan Drug Status for Remdesivir
CVS Caremark Implements Measures to Protect COVID-19 Supply Chain
Revamping Biosimilar Reviews to Spur Drug Development in Oncology
Suppliers Unable to Meet Orders for Potential COVID-19 Drugs
Vivli Launches COVID-19 Portal to Share Clinical Trial Data
Graphics Processing Units Tech to Accelerate COVID-19 Sequencing
HHS Funds Clinical Trial for Potential COVID-19 Treatment
Gilead Halts Access to Potential COVID-19 Drug Remdesivir
COVID-19 Concerns at US Clinical Trial Sites Jump 88% Over 4 Days
Lopinavir- Ritonavir Not Effective in Adults with Severe COVID-19
Court Tells Mallinckrodt to Pay $650M in Back Medicaid Rebates
FDA Approves Roche’s Biomarker Test for At-Risk HPV Infections
GSK, Chapel-Hill Renew $20M Partnership to Discover HIV Treatment
MassBio, Bayer Launch Center for Startups in the Biotech Space
FDA Proposes Broad Approach to Clinical Trials for Diabetes Drugs
FDA Authorizes Additional COVID-19 Testing in New York
Phase 1 Clinical Trial for Coronavirus Vaccine Begins in Seattle
Patients Benefiting from Immune Checkpoint Inhibitor Drugs Limited
Latest Coronavirus Updates for the Healthcare Community
Major NY Opioid Trial in Delayed Due to COVID-19 Concerns
Pharmacy Benefit Managers Prepared to Tackle COVID-19
Cell and Gene Therapy Development Increased 20%, PhRMA Finds
$125M Initiative to Boost Drug Discovery for COVID-19 Treatment
FDA, FTC Warn Companies to Stop Selling Fraudulent COVID-19 Drugs
First Gene Therapy Clinical Trial to Address Genetic Blindness
FDA Provides Coronavirus Supply Chain Update
Prescription Drug Prices Spike Following FDA Approval, Study Finds
Gene Therapy, Regenerative Medicine Markets Booming Worldwide
FDA Approves First Generic Drug Version of Daraprim
Pharma Companies Spent $985M On New Drug Development
Feds Charge Sandoz for Fixing Generic Drug Prices
New Ruling to Expand Public Access to Clinical Trial Data
Former SARS, MERS Drug Could Treat COVID-19 Patients
Sanofi to Pay $11.85M to Resolve Medicare Fraud Allegations
Prescription Drug Costs Increased 3X Over the Past Decade
Policymakers Call Out Express Scripts Over Rising Insulin Prices
ICER: New Migraine Drugs Not as Expensive as Previously Thought
CA Firm Files Wrongful Death Lawsuit Over Opioid Dependence Drug
Pharma Company Earns $311M for Cannabinoid Medicines
What the New Coronavirus Means for the Pharmaceutical Industry
FDA Boosts Affordable Access to Insulin and Biological Products
ICER, Aetion to Boost Real-World Evidence for Clinical Trials
FDA Develops Web-Based Resource to Support Pharmacogenetics
Esperion Earns FDA Approval for Cholesterol Lowering Drug Nexletol
NIH Launches Clinical Trial for Potential Coronavirus Vaccine
GSK Sells 15 Consumer OTC Products to German Pharma Company STADA
Organizations Demand Clinical Trial Coverage for Medicaid Patients
Members of Congress Demand Fair Drug Pricing for COVID-19 Vaccines
Machine Learning Supports Effective Antibiotic Discovery
International Reference Pricing Implementation Challenges
IBM Watson Unveils Cloud-Based Clinical Trial Efficiency Tech
Former Pharma Executive Pleads Guilty to Antitrust Conspiracy
HHS, J&J Partner to Boost Vaccination Discovery for Coronavirus
FDA, Indian Government Stop 500 Illicit Prescription Drug Shipments
Prescription Drug Prices Rose 21% as Utilization Remained Steady
Pharmaceutical Company Mallinckrodt Sued Over Seizure Drug Cost
CMS Launches New Billing Code for Coronavirus Testing
GoodRx Names Top 20 Most Expensive Prescription Drugs in 2020
Children’s Hospitals Team Up to Link Patients to Clinical Trials
Congress’ Think Tank Digs Into Drug Patenting Practices
Industry Backs FDA Guidance on Patient-Focused Drug Development
Machine Learning Moves the Needle on Personalized Antidepressants
HHS Launches Foundry for American Biotechnology to Spur Innovation
Chronic Disease Management Drug Shows Real-World Efficacy
Biogen Triumphs Over Patent Challenge of Multiple Sclerosis Drug
CMS Moves to Foster Access to Generics, Biosimilars in New Rule
White House Releases Drug Control Strategy for 2020
Many Antibiotics Prescribed Without ‘Clear Rationale,’ Study Says
WHO Touts Vaccines in Global Principles Against Cancer
FDA, FTC Join Forces on Biologics Competition
Opposition to International Pricing Index for Part B Drugs Mounts
FDA Breaks Down Barriers to Prioritizing Generic Drug Approvals
FDA Aims to Bolster Gene Therapy Development with New Guidance
Illinois Caps Out-of-Pocket Costs for Insulin at $100 for Insured
FTC, NY Sue to Ban Martin Shkreli From Pharmaceutical Industry
CEPI Pushes for Vaccine as Coronavirus Spreads
Insys’ John Kapoor Sentenced to 66 Months for Opioid Scheme
Biotech to be ‘Extremely Active’ in 2020 Mergers and Acquisitions
National Diabetes Prevention Program Expands to Pharmacies
Improving Vaccination Efforts Requires Renewed Commitment
GlaxoSmithKline Leads Group Combatting Antimicrobial Resistance
GAO Backs Machine Learning in Drug Development
Eli Lilly Snags $470M for NC Drug Manufacturing Plant
USMCA Approval Signals Drug Pricing Changes Ahead
FDA Proposes Policies for Pediatric Studies
Study: FDA Should Simplify Drug Approval Programs
2020 Poised to be Another Life Sciences M&A ‘Mega’ Year
FDA Taps Google Cloud for Real World Evidence Use
Industry Supports FDA’s Reorganization of Office of New Drugs
Definitive Healthcare Acquires PatientFinder, Eyes Life Sciences
GAO Flags Lack of 340B Drug Discount Program Oversight
CA Proposes Single Market for Drug Pricing, Manufacturing Hub
USMCA Makes its Way to Full Senate Vote After Lobbying Win
FTC Thwarts $1.2B Illumina-Pacific Biosciences Takeover
Drug Price Hikes Undeterred Despite Legislative Proposals
Oncologists Influence Peers in Prescribing Novel Therapies